(Q43723158)

26 November 2017

title

The relationship between obesity and mortality in patients with heart failure (English)

1 reference

26 November 2017

0 references

0 references

2

1 reference

26 November 2017

Horwich TB

1

1 reference

26 November 2017

Hamilton MA

3

1 reference

26 November 2017

MacLellan WR

4

1 reference

26 November 2017

Woo MA

5

1 reference

26 November 2017

Tillisch JH

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

789-795

1 reference

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Guidelines for healthy weight

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Prevalence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Obesity : impact on cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Obesity and cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Obesity and Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a young, morbidly obese patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Differential clinical prognostic classifications in dilated and ischemic adbanced heart failure: The EPICAL study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

The endotoxin-lipoprotein hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

The role of tumor necrosis factor in the pathophysiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Hormones and hemodynamics in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901448-6

7 January 2021

10.1016/S0735-1097(01)01448-6

Identifiers

DOI

1 reference

26 November 2017

1 reference